| Literature DB >> 32719756 |
Baukje M Dotinga1, Jonathan P Mintzer2, James E Moore3, Jan B F Hulscher4, Arend F Bos1, Elisabeth M W Kooi1.
Abstract
Nutrient requirements of preterm neonates may be substantial, to support growth and maturation processes in the presence of challenging post-natal circumstances. This may be accompanied by substantial intestinal oxygen requirements. Preterm neonates may not be able to meet these oxygen requirements, due to a developmental delay in intestinal oxygenation regulation mechanisms. This review summarizes the available literature on post-natal maturation of intestinal oxygenation mechanisms and translates these changes into clinical observations and potential implications for preterm neonates. The different mechanisms that may be involved in regulation of intestinal oxygenation, regardless of post-natal age, are first discussed. The contribution of these mechanisms to intestinal oxygenation regulation is then evaluated in newborn and mature intestine. Finally, the course of clinical observations is used to translate these findings to potential implications for preterm neonates.Entities:
Keywords: growth and development; intestinal circulation; intestinal oxygenation; near-infrared spectroscopy; newborn; preterm neonates
Year: 2020 PMID: 32719756 PMCID: PMC7347753 DOI: 10.3389/fped.2020.00354
Source DB: PubMed Journal: Front Pediatr ISSN: 2296-2360 Impact factor: 3.418
Figure 1Overview of mechanisms regulating intestinal oxygenation. ET-1, endothelin-1; NO, nitric oxide.
Search strategy.
| 1 | Intestine, small [mh] | 160,222 |
| 2 | Splanchnic circulation/physiology [mh] | 2,523 |
| 3 | Intestine, small/blood supply | 6,624 |
| 4 | Intestine, small/physiology [mh] | 52,907 |
| 5 | Mesenteric arteries [mh] | 16,536 |
| 6 | Splanchnic [tiab] | 9,642 |
| 7 | Abdom | 344,335 |
| 8 | Intestin | 361,977 |
| 9 | Mesenter | 59,868 |
| 10 | 815,899 | |
| 11 | Hemodynamics/physiology [mh] | 153,990 |
| 12 | Vascular resistance/physiology [mh] | 7,376 |
| 13 | Vasoconstriction/physiology [mh] | 6,745 |
| 14 | Vasodilation/physiology [mh] | 10,143 |
| 15 | Hemodynamics [tiab] | 48,463 |
| 16 | Vascular resistance [tiab] | 31,064 |
| 17 | Vasoconstrict | 42,933 |
| 18 | Vasodilat | 67,236 |
| 19 | Perfusion [tiab] | 159,441 |
| 20 | Circulat | 403,596 |
| 21 | Blood flow [tiab] | 167,197 |
| 22 | Oxygenation [tiab] | 51,192 |
| 23 | 924,027 | |
| 24 | 49,658 | |
| 25 | Infant, Newborn [mh] | 600,550 |
| 26 | Infant [tiab] | 216,859 |
| 27 | Newborn [tiab] | 137,450 |
| 28 | Neonat | 263,693 |
| 29 | Post-natal [tiab] | 103,008 |
| 30 | Develop | 4,280,256 |
| 31 | 5,003,395 | |
| 32 | 9,837 | |
| 33 | Ultrasonography [mh] | 70,985 |
| 34 | Doppler [tiab] | 102,865 |
| 35 | Spectroscopy, Near-Infrared [mh] | 13,026 |
| 36 | Near-infrared spectroscopy [tiab] | 11,392 |
| 37 | 490,849 | |
| 38 | 330 | |
| 39 | Preterm [tiab] | 67,490 |
| 40 | 145 | |
search number;
truncation; mh, MeSH term; tiab, title or abstract
Figure 2Search strategy. (A) Postnatal maturation of intestinal oxygenation mechanisms, (B) Clinical observations. N/A, not applicable.
Postnatal maturation of intestinal oxygenation mechanisms.
| 1988 | Crissinger et al. ( | Swine | 20 | 1, 3 d, 2 wk, 1 mo | Venous pressure elevations led to reductions in blood flow and increases in (a–v)O2. Oxygen uptake increased in animals aged 1 day and remained unchanged in animals aged 3 days. Total vascular resistance decreased in response to venous pressure elevation in animals aged 1 day and increased in animals aged 3 days. | Venous pressure elevation led to decreased blood flow, increased (a–v)O2 and decreased oxygen uptake. Total vascular resistance increased in response to venous pressure elevations. | Venous pressure elevation led to greater reductions in blood flow and oxygen uptake in all older animals compared to animals at day 1. Predominance of metabolic factors at day 1 and myogenic factors in older animals is suggested as evidenced by the total vascular resistance. |
| 1988 | Nowicki et al. ( | Swine | 18 | 3, 35 d | Blood flow decreased in response to reductions in perfusion pressure. Oxygen uptake increased in response to reductions in perfusion pressure. Pressure-flow autoregulation was absent. | Blood flow decreased in response to reductions in perfusion pressure. Oxygen uptake increased in response to reductions in perfusion pressure. Pressure-flow autoregulation was present. | Pressure-flow autoregulation was only present in older animals. Blood flow decreased and oxygen uptake increased to a similar extent in both age groups. As a consequence, oxygen uptake was more effectively maintained in older animals. |
| 1990 | Nowicki et al. ( | Swine | 26 | 3, 35 d | During free flow, blood flow decreased and (a–v)O2 initially remained unchanged in response to venous pressure elevation, therefore oxygen uptake decreased. Greater venous pressure elevation led to increased (a–v)O2 and maintained oxygen uptake. | During free flow, blood flow decreased and (a–v)O2 remained unchanged in response to venous pressure elevation, therefore oxygen uptake decreased. | In response to venous pressure elevation, blood flow and oxygen uptake decreases to a greater extent in newborn animals. |
| 1991 | Nowicki et al. ( | Swine | 15 | 3, 35 d | Oxygen uptake decreased in response to arterial pressure reduction. Pressure-flow autoregulation was absent. | Oxygen uptake was maintained during arterial pressure reduction. Pressure-flow autoregulation was present and associated with venous PO2, but not with blood flow. | Pressure-flow autoregulation was only present in older animals. Oxygen uptake was only maintained in older animals. |
| 1992 | Nowicki et al. ( | Swine | 14 | 3, 35 d | Increased oxygen demand led to greater oxygen uptake resulting from increased (a–v)O2. Pressure-flow autoregulation was absent. | Increased oxygen demand led to greater oxygen uptake resulting from increased (a–v)O2. Pressure-flow autoregulation was present. | Pressure-flow autoregulation was only present in older animals. |
| 1993 | Nowicki et al. ( | Swine | 24 | 3, 35 d | Pressure-flow autoregulation was absent. The (a–v)O2 increased in response to perfusion pressure reductions, but the magnitude of the increase diminished with lower pressures. Oxygen uptake decreased significantly in response to perfusion pressure reductions. | Pressure-flow autoregulation was present. The (a–v)O2 increased in response to perfusion pressure reductions. Oxygen uptake only decreased in response to the greatest reduction in perfusion pressure | Pressure-flow autoregulation was only present in older animals. Oxygen uptake was only maintained in older animals. |
| 1995 | Nankervis et al. ( | Swine | 10 | 3, 35 d | Inhibited NO production increased vascular resistance and (a–v)O2, no changes in oxygen uptake were observed. Vasodilation was observed in response to increased flow. Inhibited NO production increased vascular resistance during increased flow rates. | Inhibited NO production did not affect vascular resistance, nor oxygen uptake. Vasodilation was observed in response to increased flow. Inhibited NO production did not have an effect on vascular resistance during increased flow. | Only in newborn animals, the NO-cGMP axis participates in setting basal vascular resistance and in flow-induced dilation. Flow-induced dilation was present in both age groups. |
| 1997 | Nakanishi et al. ( | Rabbits | 36 | 3–5 d, 4–8 mo | Inhibited Ca2+-influx caused vasorelaxation. Stimulated Ca2+-release from intracellular store sites caused vasoconstriction. | Inhibited Ca2+-influx caused vasorelaxation. Stimulated Ca2+-release from intracellular store sites caused vasoconstriction. | Newborn animals showed greater vasoconstriction in response to stimulated Ca2+-release from intracellular stores, whereas older animals showed greater vasorelaxation in response to inhibited Ca2+-influx through Ca2+-channels across the sarcolemma. |
| 1998 | Nowicki ( | Swine | 14 | 3, 35 d | Blood flow decreased, (a–v)O2 increased and oxygen uptake decreased in response to reduced flow, achieved by perfusion pressure reductions. Vascular resistance increased in response to perfusion pressure reductions. | Blood flow decreased, (a–v)O2 increased and oxygen uptake remained unchanged in response to reduced flow, achieved by perfusion pressure reductions. Vascular resistance increased in response to perfusion pressure reductions. | In newborn animals, vascular resistance increases to a greater extent in response to perfusion pressure reductions. Oxygen uptake is only maintained in older animals during perfusion pressure reductions. |
| 1998 | Reber et al. ( | Swine | 14 | 3, 35 d | Myogenic vasoconstriction in response to increased intravascular pressure was present. Flow-mediated dilation was present. Vasodilation was noted in response to combined increases in pressure and flow. Pressure-flow autoregulation was absent. | Myogenic vasoconstriction in response to increased intravascular pressure was absent. Flow-mediated dilation in response to increased flow was present. A modest degree of pressure-flow autoregulation was observed. | Myogenic vasoconstriction was only observed in newborn animals. A greater degree of flow-induced dilation was observed in newborn animals. Vasodilation in response to combined increases in pressure and flow was only observed in newborn animals. Pressure-flow autoregulation was only present in older animals. |
| 1999 | Nowicki ( | Swine | 50 | 3, 35 d | Vasoconstriction was observed in response to reduction of flow rate. Inhibited NO production increased vascular resistance. Low flow conditions caused increased vasoconstriction in response to ET-1 and these effect were even greater during inhibited NO production. | Vasoconstriction was observed in response to reduction of flow rate. Inhibited NO production increased vascular resistance. Low flow conditions did not alter the response to ET-1. | In newborn animals, low flow conditions caused greater vasoconstriction and a greater vasoconstrictor response to ET-1. Inhibited NO production increased vascular resistance to a greater extent in newborn animals. |
| 2000 | Nankervis et al. ( | Swine | 10 | 3, 35 d | Infusion of ET-1 caused vasoconstriction and decreased (a–v)O2. Oxygen uptake was compromised during ET-1 infusion. Blockade of ETA-receptors did not alter basal vascular tone. Blockade of ETB-receptors increased the extent of vasoconstriction, but had no effect on (a–v)O2. | Infusion of ET-1 caused vasoconstriction and decreased (a–v)O2. Oxygen uptake was compromised during ET-1 infusion. Blockade of ETA-receptors did not alter basal vascular tone. Blockade of ETB-receptors had no effect on vessel diameter, nor (a–v)O2. | In newborn animals, endogenous ET-1 participates in exchange vessel regulation, but not in setting basal vascular tone. Vasoconstriction caused by endogenous ET-1 is offset by vasodilation by activation of ETB-receptors, but only in newborn animals. In newborn animals, ET-1 infusion leads to greater increases in (a–v)O2. |
| 2000 | Nankervis et al. ( | Swine | 10 | 3, 35 d | Blockade of ETA-receptors did not alter basal vascular resistance, but increased oxygen uptake. Blockade of ETB-receptors and removal of the endothelium increased vasoconstriction in response to ET-1. | Blockade of ETA-receptors did not alter basal vascular resistance, nor oxygen uptake. Blockade of ETB-receptors and removal of the endothelium did not alter vasoconstriction in response to ET-1. | ETB-receptors are located on the endothelium and modulate the vasoconstrictor response to ET-1, but only in newborn intestine. |
| 2001 | Nankervis et al. ( | Swine | 10 | 1, 40 d | Myogenic vasoconstriction was observed in response to increased vascular pressure under no-flow circumstances, whereas vasodilation was observed in the presence of flow. Blockade of ETA-receptors caused vasodilation, but only in the absence of flow. Blockade of ETB-receptors and NO production caused vasoconstriction regardless of flow conditions. | Myogenic vasoconstriction in response to increased arterial pressure was absent, instead vasodilation was observed. Blockade of ETA-receptors, ETB-receptors and NO production produced no effect on vessel diameter. | Myogenic vasoconstriction in response to increased arterial pressure was only observed in newborn animals. In newborn animals, ET-1 participates in setting basal vascular tone, independent of the myogenic mechanism, that is offset by activation of ETB-receptors. |
| 2001 | Nankervis et al. ( | Swine | 12 | 1, 40 d | ETA-receptors were present and localized to vascular smooth muscle. ETB-receptors were present and localized to the endothelium. | ETA-receptors were present and localized to vascular smooth muscle. ETB-receptors were present and localized to the endothelium. | ETA- and ETB-receptors are present in a greater quantity in newborn intestine compared with mature intestine. |
| 2001 | Reber et al. ( | Swine | 10 | 3, 35 d | NO production increases and vascular resistance decreasing in response to increases in flow rate. Increased NO production was observed in response to decreases in flow rate, but vascular resistance remained unchanged. | NO production and vascular resistance remained unaltered in response to both increases and decreases in flow rate. | Basal NO production and stimulated NO production in response to increased flow rate were greater in newborn animals. Only in newborn animals, flow-induced dilation was observed. |
| 2002 | Reber et al. ( | Swine | 30 | 1, 3, 10, 30 d | Expression of eNOS protein was present. Blockade of NO production increased vascular resistance. | Expression of eNOS protein was present. Blockade of NO production increased vascular resistance at day 10, but not at day 30. | Expression of eNOS protein increased until day 10, but then decreased until day 30, whereas eNOS mRNA remained stable. Compared to 1-day-old animals, vascular resistance was higher in 30-day-old animals. Oxygen uptake increased until day 3, but then decreased until day 30. |
| 2003 | Su et al. ( | Swine | 40 | 1, 10 d | Vasoconstriction was observed in response to increased intravascular pressure. Blockade of PKC eliminated this vasoconstrictor response. Activation of PKC increased the contractile response. | No change in vessel diameter was observed in response to increased intravascular pressure. Neither blockade of PKC nor activation of PKC produced any changes in vessel diameter. | The intensity of myogenic vasoconstriction is greater in newborn animals. Myogenic vasoconstriction was attenuated by blockade and activation of PKC, but only in newborn animals. |
| 2004 | Su et al. ( | Swine | 12 | 3, 10, 30 d | ETA- and ETB-receptor mRNA and protein expression was present. The ETA-receptor was localized to vascular smooth muscle and the ETB-receptor was localized to the endothelial layer. | ETA- and ETB-receptor mRNA and protein expression was present. The ETA-receptor was localized to vascular smooth muscle and the ETB-receptor was localized to the endothelial layer. | ETA- and ETB-receptor mRNA and protein expression was greater in newborn animals. Localization of ETA- and ETB-receptors was similar. |
| 2005 | Wendel et al. ( | Rats | 15 | 0, 5, 14, 21, 28 d, adult | ETB-receptors were absent on smooth muscle cells in the mesenteric circulation | From day 14, ETB-receptors were present on smooth muscle cells of mesenteric arterioles, but not arteries and veins | ETB-receptors are only present on smooth muscles cells of mesenteric arterioles in mature intestine |
| 2020 | Ayuso et al. ( | Swine | 22 | 0, 3, 8, 19 d | In LBW animals, eNOS is present at birth in a moderate degree. In NBW animals, eNOS expression peaks at birth. | In both LBW and NBW, animals, eNOS expression is present in a moderate degree. | eNOS expression is greater in newborn animals than in mature animals, but only in NBW animals. |
| 1985 | Buckley et al. ( | Swine | 34 | 1, 2–4 d, 1, 2 wk, 1 mo | An increase in vascular resistance was observed in response to inhibition of the baroreceptor reflex, achieved by occlusion of the carotid arteries. The circulation is under neural vasoconstrictor tone, as evidenced by decreased vascular resistance in response to section of the splanchnic nerve. SpNS produced vasoconstriction. | An increase in vascular resistance was observed in response to inhibition of the baroreceptor reflex, achieved by occlusion of the carotid arteries. The circulation is under neural vasoconstrictor tone, as evidenced by decreased vascular resistance in response to section of the splanchnic nerve. Increased vascular resistance was observed in response to SpNS and MNS. | The mesenteric circulation participated in the baroreceptor reflex in all age groups. Neural factors participate in setting basal vascular tone from birth onwards, but the decrease in vascular resistance observed in response to splanchnic nerve section was greater in older animals. Vascular resistance increased to a greater extent in older animals in response to SpNS. |
| 1987 | Buckley et al. ( | Swine | 34 | 6 h-2 d, 4–7 d, 2 wk, 1, 2 mo | Inhibition of the baroreceptor reflex increased vascular resistance. Severing the major components of the innervation increased flow. Vasoconstriction was observed in response to mesenteric nerve stimulation. Autoregulatory escape in response to sustained MNS was not observed. | Inhibition of the baroreceptor reflex increased vascular resistance. Severing the major components of the innervation increased flow. Vasoconstriction was observed in response to mesenteric nerve stimulation. Autoregulatory escape in response to sustained MNS was observed. | From birth, the mesenteric circulation is under neural vasoconstrictor tone and participates in the baroreceptor reflex. The increase in vascular resistance was greater and the latencies for the onset of vasoconstriction in response to MNS were smaller in older animals. From the age of 2 weeks, autoregulatory escape during sustained MNS is demonstrable and it is well-established by the end of the first month. |
| 1991 | Nowicki et al. ( | Swine | 22 | 3, 35 d | Vasoconstriction was observed in response to MNS. Autoregulatory escape was observed in response to sustained MNS, however oxygen uptake remained below baseline. | Vasoconstriction was observed in response to MNS. Autoregulatory escape was observed in response to sustained MNS, however oxygen uptake remained below baseline. | Sustained MNS produced similar effects on vascular resistance and oxygen uptake in newborn and older animals. Both age groups demonstrated autoregulatory escape. |
| 1996 | Hoang et al. ( | Swine | 22 | 0–2, 10–14 d | Neither α1- and α2-adrenoceptors seem to play a role in the vasoconstrictor response to α1- and α2-agonists, as evidenced by an unaltered response in the presence of α1- and α2-antagonists. | Specific, functional α1- and α2-adrenoceptors were present, as evidenced by blockade of the vasoconstrtictor response to α1- and α2-agonists in the presence of α1- and α2-antagonists, respectively. | Selectivity of α1- and α2-adrenoceptor activity was only observed in older animals. |
| 1998 | Nowicki ( | Swine | 10 | 3, 35 d | SP is present. Infusion of SP causes vasodilation and increases oxygen uptake. Blockade of SP NK-1 receptors increases basal vascular resistance. Blockade of NO production eliminates SP-induced vasodilation and increases basal vascular resistance. | SP is present. Infusion of SP causes vasodilation and increases oxygen uptake. Blockade of SP NK-1 receptors did not alter basal vascular resistance. Blockade of NO production eliminates SP-induced vasodilation. | SP content is greater in newborn animals. SP participates in setting basal vascular resistance, but only in newborn animals. |
| 2007 | Gonzáles-Luis et al. ( | Swine | 24 | 1, 2 wk | Electrical field stimulation, in the absence of cholinergic and adrenergic components, produced vasodilation, that was eliminated during blockade of NO production. | Electrical field stimulation, in the absence of cholinergic and adrenergic components, produced vasodilation. | Non-adrenergic, non-cholinergic relaxation was greater in newborn animals and was eliminated during blockade of NO production. |
(a–v)O.
Clinical studies in preterm neonates.
| 1990 | Van Bel et al. ( | Preterm and term (GA 24–43 wk) | 91 | 1–5, daily | PI increased between 1 and 6 days. No significant changes were observed for PSV, TAMV, and EDV. Values for PSV, TAMV, and EDV increased with advancing GA. PI was not associated with GA. In SGA infants, EDV was significantly higher on day 1 and PI was significantly lower on days 1–2 compared to AGA infants. |
| 1992 | Coombs et al. ( | Preterm (GA 27–35 wk) and term (GA 37–41 wk) | 18 | 1, 2, 4 d | In term infants, an increase in PSV was observed between 1 and 2 days. In preterm infants, no significant changes were observed in PSV between 1 and 4 days. No significant difference was observed for PSVbetween term and preterm infants. |
| 1996 | Martinussen et al. ( | Preterm (GA 33–35 wk) | 15 | 1–7 d, daily | An increase in TAMV and EDV was observed between 1 and 2 days. EDV was positive in all infants examined between 6 and 24 h. No changes were observed after day 3. |
| 1999 | Maruyama et al. ( | Preterm (GA 28–33 wk) | 44 | 1–6 d, daily | An increase in TAMV was observed between 1 and 6 days. A decrease in RI was observed between 1 and 2 days, and then an increase to 6 days. A decrease in RVR was observed between 1 and 6 days. |
| 1999 | Yanowitz et al. ( | VLBW (BW 750–1,250 g) | 20 | 6, 30, 54 h, 7, and 14 d | An increase in TAMV was observed between 6 h and 7 days and between 6 h and 14 days. No significant changes were observed in EDV and RVR. |
| 2001 | Maruyama et al. ( | VLBW, SGA (BW <1,500 g and below the 10th percentile | 10 | 1–7 d, daily | An increase in PSV was observed between 1 and 6–7 days. An increase in TAMV was observed between 1 and 5–6 days. An increase in EDV was observed between 1 and 3–7 days. A decrease in RI was observed between 1 and 2–7 days. A decrease in RVR was observed between 1–6 days. PSV, TAMV, and EDV were lower in SGA infants compared to AGA infants. |
| 2006 | Havranek et al. ( | Preterm (GA <34 wk) | 25 | 1–5 d, daily | An increase in PSV and TAMV was observed between 1 and 5 days. |
| 2009 | Papacci et al. ( | Preterm (GA 25–28 wk, 29–32 wk, 33–36 wk) and term (GA 37–41 wk) | 69 | 1, 3, 7, 14, 21, and 28 d | An increase in PSV, EDV and TAMV was observed between 1 and 28 days. Values for PSV, EDV, and TAMV increased with advancing GA. No changes in PI an RI were observed. |
| 2012 | Havranek et al. ( | VLBW (BW <1,500 g) | 35 | 1, 3, 5, 7, 10, and 14 d | An increase in PSV and TAMV was observed between 1 and 14 days. Lower values on day 1 were associated with higher post-natal increases in PSV and TAMV. No change in EDV was observed. No correlation was found between GA and day 1 PSV and TAMV. |
| 2014 | Thompson et al. ( | Preterm (GA <27 wk, 27–31 wk, and 31–36 wk) | 41 | 1, 1–4, 5–7, 8–14, and 15–28 | No differences were observed in PSV on day 1 between GA groups. However, on day 5–7 and 8–14 higher GA was associated with higher PSV. |
| 2015 | Gursoy et al. ( | Preterm (GA 26–34 wk) | 25 | 1–5 d, daily | An increase in PSV, TAMV and EDV was observed between 1 and 5 days. A decrease in RI was observed between 1 and 5 days. |
| 2018 | Kocvarova et al. ( | Preterm (GA 34–37 wk) and term (GA 38–42 wk) | 40 | 2, 24, and 72 h | An increase in PSV was observed between 2 and 72 h. An increase in EDV was observed between 2 and 24 h. All EDV values were positive at 24 h. An increase in TAMV was observed between 2 and 24 h and between 24 and 72 h. A decrease in PI and RI was observed between 2 and 24 h. Preterm infants had lower PI at 2 h and higher PSV and EDV at 24 h compared to term infants. |
| 2010 | Cortez et al. ( | Preterm (GA ≤ 30 wk) | 19 | 48 h-14 d, continuously | A decrease in daily mean rsSO2 was observed between 48 h until 9 days, and then an increase between 10 and 14 days. |
| 2011 | McNeill et al. ( | Preterm (GA 29–30 wk and 32–33 wk) | 12 | 0–21 days, continuously | A decrease in daily mean rsSO2 was observed between 1 and 7 days in infants with GA 29–30 wk and between 1 and 4.5 days in infants with GA 32–33 wk. Afterwards, an increase in rsSO2 was observed. Lower GA was associated with lower rsSO2 values. |
| 2014 | Patel et al. ( | Preterm (GA <32 wk and birth weight <1,500 g) | 92 | 0–7 d, 5 min daily | An increase in mean rsSO2 was observed between 1 and 3 days. Afterwards, a decrease in rsSO2 was observed. |
| 2016 | Bozzetti et al. ( | Preterm (GA 29–33 wk) | 20 | 0–24, 48–72, 3 h daily | A decrease in rsSO2 was observed between 0–24 h and 48–72 h. In IUGR infants rsSO2 was significantly lower compared to non-IUGR infants. |
| 2017 | Ledo et al. ( | Preterm (GA <32 wk) | 72 | 36 h-7 d, continuously | An initial decrease in rsSO2 was observed for all infants, regardless of DA status. An increase in rsSO2 was observed after closure of the DA at day 3. No increase in rsSO2 until day 7 was observed in infants with persistent hsPDA. |
| 2019 | Kuik et al. ( | Preterm (GA <30 wk, or birth weight <1,000 g, or GA <32 wk and birth weight <1,200 g | 29 | 2–5, 8, 15, 22, 29, 36 d, 2 h on each day | Generally, an increase in rsSO2 was observed between 2 and 36 days, with the lowest values on day 4 and day 15. |
BW, birth weight; d, days; DA, ductus arteriosus; EDV, end-diastolic velocity; GA, gestational age; h, hours; NIRS, near-infrared spectroscopy; PI, pulsatility index; PSV, peak systolic velocity; RI, resistance index; r.